通过专为投资者打造的一站式数据看板，全面查看 Kymera Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

9.64B

股息TTM

0.00

市盈率 TTM

-32.56

每股收益TTM

-3.58

营业收入

39.21M

净利润

-223.86M

净资产收益率

-27.09%

总资产收益率

-24.35%

Kymera Therapeutics Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

34.53%-0.62

13.25%-0.71

-9.53%-0.97

-14.67%-0.94

-65.42%-0.95

-19.26%-0.82

-259.40%-0.88

9.29%-0.82

13.45%-0.58

2.46%-0.69

59.21%-0.25

---0.90

---0.67

---0.70

---0.60

---2.28

----

营业收入

466.40%65.00M

55.50%34.37M

-61.18%2.87M

-26.12%2.76M

-55.26%11.48M

114.83%22.10M

-84.56%7.39M

-20.88%3.74M

55.33%25.65M

8.67%10.29M

196.70%47.88M

-50.50%4.73M

43.42%16.51M

-1.62%9.47M

5.66%16.14M

-53.03%9.55M

-37.83%11.51M

-48.55%9.62M

19.48%15.28M

39.93%20.34M

净利润

20.10%-61.21M

-5.57%-69.23M

-22.94%-86.98M

-31.51%-82.17M

-82.15%-76.61M

-35.06%-65.58M

-392.43%-70.75M

-18.20%-62.49M

-8.41%-42.06M

-18.64%-48.56M

58.79%-14.37M

-22.94%-52.87M

3.62%-38.80M

-11.57%-40.93M

-2.85%-34.87M

-50.45%-43.00M

-63.25%-40.26M

-180.57%-36.68M

-167.24%-33.90M

-257.90%-28.58M

利润率

85.89%-94.17%

32.11%-201.47%

-216.73%-3030.70%

-77.99%-2973.05%

-307.11%-667.60%

37.13%-296.75%

-3089.06%-956.88%

-49.38%-1670.33%

30.21%-163.98%

-9.17%-472.02%

86.11%-30.01%

---1118.17%

---234.96%

---432.37%

---216.03%

---390.86%

----

毛利率

0.00%100.00%

--100.00%

----

资产负债率

-59.61%0.15%

-54.74%0.17%

-50.88%0.19%

12.37%0.34%

55.23%0.36%

43.21%0.38%

-14.51%0.38%

-0.31%0.30%

-31.60%0.23%

-30.48%0.26%

1.76%0.45%

--0.30%

--0.34%

--0.38%

--0.44%

--0.28%

----

利润表

营业收入

466.40%65.00M

55.50%34.37M

-61.18%2.87M

-26.12%2.76M

-55.26%11.48M

114.83%22.10M

-84.56%7.39M

-20.88%3.74M

55.33%25.65M

8.67%10.29M

196.70%47.88M

-50.50%4.73M

43.42%16.51M

-1.62%9.47M

5.66%16.14M

-53.03%9.55M

-37.83%11.51M

-48.55%9.62M

19.48%15.28M

39.93%20.34M

营业利润

10.58%-75.61M

-13.07%-84.15M

-21.23%-97.90M

-22.94%-88.67M

-66.04%-84.56M

-40.68%-74.43M

-318.16%-80.75M

-25.41%-72.12M

-17.38%-50.92M

-16.72%-52.91M

50.01%-19.31M

-28.13%-57.51M

-6.30%-43.38M

-22.72%-45.33M

-13.64%-38.63M

-56.73%-44.88M

-65.02%-40.81M

-180.45%-36.93M

-165.95%-33.99M

-254.29%-28.64M

净利润

20.10%-61.21M

-5.57%-69.23M

-22.94%-86.98M

-31.51%-82.17M

-82.15%-76.61M

-35.06%-65.58M

-392.43%-70.75M

-18.20%-62.49M

-8.41%-42.06M

-18.64%-48.56M

58.79%-14.37M

-22.94%-52.87M

3.62%-38.80M

-11.57%-40.93M

-2.85%-34.87M

-50.45%-43.00M

-63.25%-40.26M

-180.57%-36.68M

-167.24%-33.90M

-257.90%-28.58M

资产负债表

流动资产

1.23%737.26M

35.23%677.43M

70.74%871.21M

-7.11%528.30M

38.62%728.33M

-6.76%500.95M

25.89%510.27M

51.38%568.72M

36.33%525.41M

30.54%537.25M

-3.36%405.32M

-23.95%375.69M

-4.31%385.40M

-4.60%411.55M

-7.06%419.42M

-9.14%494.02M

10.41%402.77M

26.58%431.38M

49.26%451.27M

82.85%543.73M

流动负债总额

-18.52%71.33M

6.19%62.64M

22.79%83.21M

7.58%71.58M

40.87%87.54M

5.08%58.99M

-20.92%67.77M

5.33%66.53M

13.81%62.14M

-9.36%56.14M

20.11%85.69M

-30.68%63.17M

-37.60%54.60M

-29.89%61.93M

-22.91%71.34M

-3.57%91.12M

-19.49%87.50M

-19.79%88.34M

-16.34%92.54M

-11.92%94.49M

总资产

45.48%1.65B

81.75%1.67B

78.20%1.74B

6.49%1.10B

36.93%1.13B

5.77%918.31M

69.87%978.03M

87.34%1.03B

41.94%826.02M

41.43%868.25M

-4.54%575.76M

-13.48%552.38M

11.18%581.95M

9.03%613.90M

-0.46%603.13M

-0.62%638.47M

20.50%523.42M

21.20%563.06M

24.37%605.90M

26.63%642.45M

总负债

-14.66%136.19M

-2.04%129.38M

14.56%163.15M

9.78%155.79M

13.11%159.59M

-15.90%132.08M

-21.22%142.42M

-9.52%141.91M

-3.70%141.10M

3.39%157.05M

60.01%180.79M

24.89%156.84M

16.77%146.52M

13.07%151.90M

-22.76%112.98M

-21.17%125.59M

-28.82%125.47M

-29.04%134.34M

-28.05%146.27M

-25.09%159.32M

总权益

55.36%1.51B

95.82%1.54B

89.04%1.58B

5.97%946.26M

41.84%971.48M

10.55%786.23M

111.56%835.62M

125.75%892.93M

57.30%684.92M

53.94%711.20M

-19.42%394.97M

-22.88%395.54M

9.42%435.43M

7.76%462.00M

6.64%490.15M

6.16%512.88M

54.18%397.95M

55.76%428.72M

61.91%459.64M

63.95%483.13M

现金流量表

经营净额

9.72%-54.06M

-12.24%-88.84M

-8.03%-66.75M

45.99%-27.11M

-39.47%-59.88M

-99.92%-79.15M

-867.98%-61.78M

-58.59%-50.19M

-21.78%-42.94M

9.95%-39.59M

120.35%8.04M

7.65%-31.65M

9.57%-35.26M

-9.12%-43.97M

-3.09%-39.54M

8.03%-34.27M

-27.77%-38.98M

-76.55%-40.30M

-91.11%-38.35M

-128.30%-37.26M

投资净额

-66.60%20.05M

-393.82%-142.84M

-675.19%-394.40M

-49.23%-235.30M

283.72%60.02M

114.70%48.62M

261.80%68.57M

-360.58%-157.68M

-56.35%15.64M

-1444.81%-330.61M

138.16%18.95M

261.44%60.51M

-56.19%35.84M

-4.95%24.58M

26.98%-49.67M

72.61%-37.48M

34.72%81.80M

-41.65%25.86M

-1604.74%-68.02M

59.06%-136.86M

融资净额

-94.13%14.42M

7174.81%18.77M

25405.21%705.22M

-84.25%39.51M

17302.69%245.73M

-99.93%258.00K

42.97%2.77M

121904.85%250.92M

8.20%1.41M

30422.52%353.76M

-0.97%1.93M

-100.14%-206.00K

258.52%1.30M

526.49%1.16M

-4.92%1.95M

-38.83%150.50M

-77.14%364.00K

-68.91%185.00K

660.74%2.05M

25.35%246.04M

营业收入

业务

报告期:

暂无数据

地区

报告期:

暂无数据

常见问题

Kymera Therapeutics Inc的总收入是多少？



根据Kymera Therapeutics Inc的FY2025财报，总收入达到了39.21M（同比变化47.07M）。

Kymera Therapeutics Inc的流动资产是多少？



根据Kymera Therapeutics Inc的FY2025财报，流动资产为871.21M（同比变化70.74）。

Kymera Therapeutics Inc的总资产是多少？



根据Kymera Therapeutics Inc的FY2025财报，Kymera Therapeutics Inc的总资产为1.74B（同比变化78.20）。

Kymera Therapeutics Inc的总负债是多少？



根据Kymera Therapeutics Inc的FY2025财报，Kymera Therapeutics Inc的总负债为163.15M（同比变化14.56）。

Kymera Therapeutics Inc的总权益是多少？



根据Kymera Therapeutics Inc的FY2025财报，Kymera Therapeutics Inc的总权益为1.58B（同比变化89.04）。

Kymera Therapeutics Inc的净营业收入是多少？



根据Kymera Therapeutics Inc的FY2025财报，Kymera Therapeutics Inc的净营业收入为-345.54M（同比变化-34.60）。

Kymera Therapeutics Inc的净投资是多少？



根据Kymera Therapeutics Inc的FY2025财报，Kymera Therapeutics Inc的净投资为-521.06M（同比变化-28.95）。

Kymera Therapeutics Inc的净融资是多少？



根据Kymera Therapeutics Inc的FY2025财报，Kymera Therapeutics Inc的净融资为990.71M（同比变化62.72）。

Kymera Therapeutics Inc的每股收益（EPS）是多少？



根据Kymera Therapeutics Inc的FY2025财报，每股收益（EPS）为-3.69（同比变化-23.53）。

Kymera Therapeutics Inc的净利润是多少？



根据Kymera Therapeutics Inc的FY2025财报，净利润为-311.35M（同比变化-39.08）。

Kymera Therapeutics Inc的净利润率是多少？



根据Kymera Therapeutics Inc的FY2025财报，净利润率为-794.04（同比变化-66.97）。

Kymera Therapeutics Inc的债务与资产比率是多少？



根据Kymera Therapeutics Inc的FY2025财报，债务与资产比率为0.19（同比变化-50.88）。

Kymera Therapeutics Inc的股东权益回报率（ROE）是多少？



根据Kymera Therapeutics Inc的FY2025财报，股东权益回报率（ROE）为-25.78（同比变化29.14）。

Kymera Therapeutics Inc的资产回报率（ROA）是多少？



根据Kymera Therapeutics Inc的FY2025财报，资产回报率（ROA）为-22.89（同比变化20.57）。

Kymera Therapeutics Inc的营业利润是多少？



根据Kymera Therapeutics Inc的FY2025财报，营业利润为-345.54M（同比变化-34.60）。